ExodusPoint Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-34,815	Closed	-$129K	–	1710
2025 Q4	$129K	Buy	+34,815	New	+$113K	﹤0.01%	1421
2024 Q4	–	Sell	-262,134	Closed	-$433K	–	1671
2024 Q3	$433K	Buy	262,134 +155,412	+146%	+$314K	﹤0.01%	1241
2024 Q2	$237K	Buy	106,722 +23,322	+28%	+$54.9K	﹤0.01%	1364
2024 Q1	$224K	Buy	+83,400	New	+$203K	﹤0.01%	1324
2023 Q2	–	Sell	-257,584	Closed	-$410K	–	1960
2023 Q1	$410K	Sell	257,584 -914,215	-78%	-$4.72M	﹤0.01%	1388
2022 Q4	$7.3M	Buy	1,171,799 +806,848	+221%	+$5.77M	0.11%	251
2022 Q3	$2.44M	Buy	364,951 +340,944	+1,420%	+$2.34M	0.03%	705
2022 Q2	$153K	Sell	24,007 -18,499	-44%	-$105K	﹤0.01%	1697
2022 Q1	$197K	Buy	42,506 +28,427	+202%	+$122K	﹤0.01%	1920
2021 Q4	$70K	Sell	14,079 -49,381	-78%	-$395K	﹤0.01%	2000
2021 Q3	$765K	Buy	+63,460	New	+$924K	0.01%	1158